Description
The purpose of this study is to characterize participants in the BE WELL trial of a life-style modification, weight loss intervention trial in patients with poorly controlled asthma in terms of their atopy phenotype and serum periostin and 8-isoprostane levels in exhaled breath condensate at baseline and follow-up, and to maintain and utilize the BE WELL serum bank for the purpose of better understanding the relation between asthma control and both obesity and weight loss.
Co-Investigators/Collaborators: John Matthews, MBBS, MRCP, PhD, and Cecile Holweg, PhD, Genentech; Carlos Camargo, Jr., MD, Dr PH, Massachusetts General Hospital and Harvard Medical School; Anne Dixon, MA, BM, BCh, University of Vermont Lung Center and College of Medicine; Sally Wenzel, MD, University of Pittsburgh Asthma Institute and School of Medicine.
Co-Investigators/Collaborators: John Matthews, MBBS, MRCP, PhD, and Cecile Holweg, PhD, Genentech; Carlos Camargo, Jr., MD, Dr PH, Massachusetts General Hospital and Harvard Medical School; Anne Dixon, MA, BM, BCh, University of Vermont Lung Center and College of Medicine; Sally Wenzel, MD, University of Pittsburgh Asthma Institute and School of Medicine.
Funder
Sutter Health and Palo Alto Medical Foundation
Research Topics
Related Studies
COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs
Project goals: To understand impacts of COVID-19 on cancer care management (detection, diagnosis, treatment), pt-reported experience, and cancer care costs.
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D., Cheryl Stults, Ph.D.
Evaluation of a Lifestyle Intervention Adopted for Clinical Practice for Diabetes Prevention (ELEVATE-DP)
This study will identify important barriers to and facilitators of translating an efficacious diabetes prevention intervention (Group Lifestyle Balance, GLB)
Investigators: Sylvia Sudat, PhD, Kristen M.J. Azar, R.N., BSN, MSN/MPH
Impact of COVID-19 on Cancer Care Management
Study will enhance understanding of cancer care management due to COVID-19.
Investigators: Su-Ying Liang, Ph.D., Monique de Bruin, M.D., MPH
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
To describe and explain variations in Lynch syndrome (LS) screening implementation across healthcare systems and create a toolkit for implementing LS screening.
Investigators: Monique de Bruin, M.D., MPH, External PI, Principal Investigator, Su-Ying Liang, Ph.D.
Improving Cancer Care
Project will provide information about referrals to palliative care and way to enhance goals of care discussions for patients diagnosed with stage IV cancer.
Investigators: Su-Ying Liang, Ph.D., Ellis C. Dillon, Ph.D.
Major Depressive Disorder
Purpose is to use EHR to understand the management of major depressive disorder in a large healthcare system, to incorporate pt-reported data in care workflow.
Investigator: Kristen M.J. Azar, R.N., BSN, MSN/MPH
Quantifying 2D and 3D MRI Imaging For Improving MS Diagnosis, Treatment, And Clinical Care
Create a longitudinal proof-of-concept MS research database (MSClinQ) that can support clinical queries, and can be updated with new tx, dx tools, care options
Investigators: Xiaowei (Sherry) Yan, PhD, MS, J.B. Jones, PhD, MBA
Stupski Serious Illness Program Evaluation
Evaluate palliative care projects at seven healthcare organizations in the SF Bay Area.
Investigators: Sylvia Sudat, PhD, Ellis C. Dillon, Ph.D.
Transforming Primary and Specialty Care for Inflammatory Bowel Disease
Use healthcare data to personalize the healthcare experience for people with inflammatory bowel disease.
Using Mobile Technology and Analytics to Track Outcomes in MS Patients
Develop an app to collect and transform pt-reported outcomes in MS for health care providers to improve care and support shared decision making.
Investigators: J.B. Jones, PhD, MBA, Xiaowei (Sherry) Yan, PhD, MS